HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Bellastella Selected Research

Glucagon-Like Peptide 1 (GLP 1)

3/2012Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Bellastella Research Topics

Disease

6Type 2 Diabetes Mellitus (MODY)
05/2019 - 05/2010
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2022 - 01/2017
4Prostatic Neoplasms (Prostate Cancer)
02/2013 - 01/2003
3Autoimmune Diseases (Autoimmune Disease)
06/2015 - 12/2011
3Hypopituitarism (Sheehan's Syndrome)
10/2014 - 10/2012
3Hypogonadism (Hypergonadotropic Hypogonadism)
05/2013 - 05/2008
2Dyslipidemias (Dyslipidemia)
02/2013 - 05/2010
2Hypertension (High Blood Pressure)
02/2013 - 05/2010
1COVID-19
02/2022
1Infections
02/2022
1Vitamin D Deficiency
09/2021
1Multiple Sclerosis
02/2020
1Metabolic Diseases (Metabolic Disease)
11/2018
1Body Weight (Weight, Body)
01/2017
1Acromegaly
11/2013
1Thyroid Diseases (Thyroid Disease)
10/2013
1Meningitis
12/2012
1Viral Meningitis
12/2012
1Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
10/2012
1Inflammation (Inflammations)
12/2011
1Addison Disease (Addison's Disease)
12/2011
1Weight Gain
07/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2010
1Autoimmune Hypophysitis
08/2008
1Hyperprolactinemia
08/2008
1Carcinoma (Carcinomatosis)
01/2006
1Graves Ophthalmopathy
01/2005
1Erectile Dysfunction
01/2005
1Graves Disease (Basedow Disease)
06/2004
1Eye Diseases (Eye Disease)
06/2004

Drug/Important Bio-Agent (IBA)

6AntibodiesIBA
10/2014 - 06/2004
4Insulin (Novolin)FDA Link
02/2017 - 05/2011
3Glucose (Dextrose)FDA LinkGeneric
02/2022 - 01/2017
3HDL CholesterolIBA
01/2017 - 05/2010
3Hormones (Hormone)IBA
05/2008 - 01/2005
2Vitamin DFDA LinkGeneric
09/2021 - 06/2015
2Thyroid HormonesIBA
04/2018 - 10/2013
2GonadotropinsIBA
05/2013 - 05/2008
2Triglycerides (Triacylglycerol)IBA
02/2013 - 05/2010
2Adrenocorticotropic Hormone (ACTH)FDA Link
12/2012 - 10/2012
2Metformin (Glucophage)FDA LinkGeneric
03/2012 - 05/2011
2AndrogensIBA
05/2011 - 01/2006
125-hydroxyvitamin DIBA
09/2021
1Alemtuzumab (Campath)FDA Link
02/2020
1Fatty Acids (Saturated Fatty Acids)IBA
11/2018
1SodiumIBA
11/2018
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2013
1Testosterone (Sustanon)FDA Link
05/2013
1Gonadal HormonesIBA
05/2013
1ProlactinIBA
05/2013
1LipidsIBA
12/2012
1GlucosidasesIBA
03/2012
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2012
1ThiazolidinedionesIBA
03/2012
1Glucagon-Like Peptide 1 (GLP 1)IBA
03/2012
1ChemokinesIBA
12/2011
1LigandsIBA
12/2011
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
12/2011
1Sitagliptin Phosphate (Januvia)FDA Link
07/2011
1alogliptinIBA
07/2011
1Dipeptidyl-Peptidase IV InhibitorsIBA
07/2011
1saxagliptinFDA Link
07/2011
1VildagliptinIBA
07/2011
1Raloxifene Hydrochloride (Evista)FDA Link
05/2011
1Estrogen ReceptorsIBA
05/2011
1Pioglitazone (Actos)FDA Link
05/2011
1Human Follicle Stimulating HormoneIBA
10/2010
1Hemoglobins (Hemoglobin)IBA
05/2010
1CabergolineFDA LinkGeneric
08/2008
1Dopamine Agonists (Dopamine Agonist)IBA
08/2008
1RetinoidsIBA
01/2006
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2005
1CollagenIBA
01/2005
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2003

Therapy/Procedure

8Therapeutics
02/2020 - 01/2006
3Glycemic Control
02/2022 - 05/2010